Micron Biomedical, Inc.

ATLANTA, GA · Medtech · Private

Needle-free, thermostable delivery device for vaccines and therapeutics

Claim this profile

Follows are private to you and power your alerts

Updated · micronbiomedical.com

Sector
Medtech
Headquarters
ATLANTA, GA
Latest Form D
$15M, Dec 2024
Total capital
$32M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$32M
3 Form D · last Dec 2024
22 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
13 pending

Capital timeline

202220232024FEDERAL ↑EQUITY ↓Cumulative $32M1st Form D$14M2nd Form D$3M3rd Form D$15M
202220232024FEDERAL ↑EQUITY ↓Cumulative $32M1st Form D$14M2nd Form D$3M3rd Form D$15M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$15M
  • Private capital raisedForm D · SEC · 2nd filing$3M
  • Private capital raisedForm D · SEC · 1st filing$14M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Bas Van BuijtenenDirectorNamed in SEC Form D filings
  • Brian BernickDirectorNamed in SEC Form D filings
  • Devin McAllisterExecutive OfficerNamed in SEC Form D filings
  • Henry SebastienExecutive OfficerNamed in SEC Form D filings
  • Idean MarvastyExecutive OfficerNamed in SEC Form D filings
  • Labeeb AbboudDirectorNamed in SEC Form D filings
Show all 11 people
  • Mark PrausnitzDirectorNamed in SEC Form D filings
  • Matthew GoldmanDirectorNamed in SEC Form D filings
  • Sebastien HenryExecutive OfficerNamed in SEC Form D filings
  • Steve DamonExecutive Officer, DirectorNamed in SEC Form D filings
  • Steven DamonExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 13
  • PendingFormulations and Methods for a GLP-1 Agonist Microneedle PatchUSPTOApplication 19284639
  • PendingMethods and Microneedle Devices for Vaccinations with Enhanced Delivery and AcceptanceUSPTOApplication 19182399
  • PendingSolid Compositions Including Stabilized Lipid Nanoparticles And Methods Of Making Microneedles Comprising SameUSPTOApplication 18898285
Show all 13 patent records
  • Formulations and Methods for a GLP-1 Agonist Microneedle PatchJan 29, 2026 · Application 19284639Pending
  • Methods and Microneedle Devices for Vaccinations with Enhanced Delivery and AcceptanceOct 23, 2025 · Application 19182399Pending
  • Solid Compositions Including Stabilized Lipid Nanoparticles And Methods Of Making Microneedles Comprising SameMar 27, 2025 · Application 18898285Pending
  • Methods And Microneedle Devices For Vaccinations With Enhanced Delivery And AcceptanceApplication PCTUS2025025233Pending
  • Microneedle Patch with Force-Feedback IndicatorApplication 19111250Pending
  • Solid Compositions Including Stabilized Lipid Nanoparticles And Methods Of Making Microneedles Comprising SameApplication PCTUS2024048646Pending
  • Formulations And Methods For A GLP-1 Agonist Microneedle PatchApplication PCTUS2025039767Pending
  • Formulations for a GLP-1 Agonist Dissolving Microneedle PatchApplication 63676750Pending
  • Methods and Microneedle Devices for Vaccinations with Enhanced Delivery and AcceptanceApplication 63646332Pending
  • Methods and Microneedle Devices for Vaccinations with Enhanced Delivery and AcceptanceApplication 63634998Pending
  • Microneedle Formulations and Methods Comprising Lipid NanoparticlesApplication 63540548Pending
  • Microneedle Patch With Force-feedback IndicatorApplication PCTUS2023032664Pending
  • Microneedle Patch with Force-Feedback IndicatorApplication 63405932Pending
  • Preceptis Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • CarePredictSimilar federal contract value in Medtech · null in contracts
  • VDYNE, INC.Similar federal contract value in Medtech · null in contracts
  • MaxQ Medical Inc.Similar federal contract value in Medtech · null in contracts
  • ADAPTIX IncSimilar federal contract value in Medtech · null in contracts
  • Provision Healthcare, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .